{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T15:27:42Z","timestamp":1771946862452,"version":"3.50.1"},"reference-count":58,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2021,8,13]],"date-time":"2021-08-13T00:00:00Z","timestamp":1628812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Aim<\/jats:title><jats:p>To examine the efficacy and safety of antiepileptic drugs (AED) for the inpatient treatment of patients with moderate to severe alcohol withdrawal syndrome (AWS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched in databases and gray literature to include randomized controlled clinical trials in adults that compare the use of AED versus placebo or any other medication. Studies that did not specify severity or were performed on an outpatient basis were excluded. The outcomes were improvement of symptoms, delirium tremens, seizures and adverse events. Two researchers independently selected the references, extracted the data and assessed the risk of bias. A qualitative synthesis was made and, when the heterogeneity was mild or moderate, a meta-analysis was performed. The quality of the evidence obtained was evaluated with the Grading of Recommendations Assessment, Development and Evaluation tool.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 26 studies with 1709 patients were included. No benefit is described in withdrawal syndrome severity measured by scales or in the development of delirium tremens. The only possible meta-analysis showed that there are no differences in the incidence of seizures (risk ratio [RR]\u2009=\u20091.0; confidence interval (CI) 95% 0.76\u20131.33), even when compared with placebo (RR\u2009=\u20090.95; CI95% 0.57\u20131.57). There were also no differences in adverse events, although a higher proportion of some mild cases were described with the use of carbamazepine and valproic acid.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The routine use of AED is not suggested in the treatment of patients with moderate or severe AWS unless indicated for comorbidity (weak recommendation against using moderate quality of evidence).<\/jats:p><\/jats:sec>","DOI":"10.1093\/alcalc\/agab057","type":"journal-article","created":{"date-parts":[[2021,7,26]],"date-time":"2021-07-26T19:11:43Z","timestamp":1627326703000},"page":"155-164","source":"Crossref","is-referenced-by-count":14,"title":["Efficacy and Safety of Anticonvulsants for the Inpatient Treatment of Alcohol Withdrawal Syndrome: A Systematic Review and Meta-analysis"],"prefix":"10.1093","volume":"57","author":[{"given":"Jenny","family":"Rojo-Mira","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, School of Medicine, Universidad de Antioquia, Medell\u00edn, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mateo","family":"Pineda-\u00c1lvarez","sequence":"additional","affiliation":[{"name":"School of Medicine, Universidad de Antioquia, Medell\u00edn, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan P","family":"Zapata-Ospina","sequence":"additional","affiliation":[{"name":"Institute of Medical Research, Grupo Acad\u00e9mico de Epidemiolog\u00eda Cl\u00ednica (GRAEPIC), School of Medicine, Universidad de Antioquia, Medell\u00edn, Colombia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,8,13]]},"reference":[{"key":"2022031410501332100_ref1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/030006058201000305","article-title":"Treatment of acute alcohol withdrawal syndrome with carbamazepine: a double-blind comparison with tiapride","volume":"10","author":"Agricola","year":"1982","journal-title":"J Int Med Res"},{"key":"2022031410501332100_ref2","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0002-9343(89)80397-3","article-title":"Placebo-controlled trial of intravenous diphenylhydantoin for short-term treatment of alcohol withdrawal seizures","volume":"87","author":"Alldredge","year":"1989","journal-title":"Am J Med"},{"key":"2022031410501332100_ref3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.podrm.2015.11.001","article-title":"Chapter three: carbamazepine","volume":"41","author":"Alrashood","year":"2016","journal-title":"Profiles Drug Subst Excip Relat Methodol"},{"key":"2022031410501332100_ref4","first-page":"25","article-title":"Kindling in alcohol withdrawal","volume":"22","author":"Becker","year":"1998","journal-title":"Alcohol Health Res World"},{"key":"2022031410501332100_ref5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13613-015-0075-7","article-title":"Addition of dexmedetomidine to benzodiazepines for patients with alcohol withdrawal syndrome in the intensive care unit: a randomized controlled study","volume":"5","author":"Bielka","year":"2015","journal-title":"Ann Intensive Care"},{"key":"2022031410501332100_ref6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/01.jcp.0000088905.24613.ad","article-title":"Treatment of acute alcohol withdrawal with gabapentin: results from a controlled two-center trial","volume":"23","author":"Bonnet","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"2022031410501332100_ref7","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1530-0277.2011.01451.x","article-title":"Long-term mortality of patients admitted to the hospital with alcohol withdrawal syndrome","volume":"35","author":"Campos","year":"2011","journal-title":"Alcohol Clin Exp Res"},{"key":"2022031410501332100_ref8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0196-0644(05)81606-3","article-title":"Emergency department treatment of alcohol withdrawal seizures with phenytoin","volume":"20","author":"Chance","year":"1991","journal-title":"Ann Emerg Med"},{"key":"2022031410501332100_ref9","first-page":"80","article-title":"A comparative study of efficacy and tolerability of lorazepam and gabapentin in the treatment of alcohol withdrawal syndrome","volume":"3","author":"Chourishi","year":"2010","journal-title":"Int J Pharm Sci Rev Res"},{"key":"2022031410501332100_ref10","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1176\/ajp.145.12.1501","article-title":"Critical review of liability for benzodiazepine abuse among alcoholics","volume":"145","author":"Ciraulo","year":"1988","journal-title":"Am J Psychiatry"},{"key":"2022031410501332100_ref11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1055\/s-0029-1202264","article-title":"Oxcarbazepine in combination with tiaprid in inpatient alcohol-withdrawal \u2013 a RCT","volume":"42","author":"Croissant","year":"2009","journal-title":"Pharmacopsychiatry"},{"key":"2022031410501332100_ref12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/00325481.1987.11699999","article-title":"Delirium tremens","volume":"82","author":"Cushman","year":"1987","journal-title":"Postgrad Med"},{"key":"2022031410501332100_ref13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2298\/SARH11S1041D","article-title":"Lamotrigine augmentation in delirium tremens","volume":"139","author":"Djokic","year":"2011","journal-title":"Srpski Arhiv Za Celokupno Lekarstvo"},{"key":"2022031410501332100_ref14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1600-0447.1984.tb02511.x","article-title":"Treatment of alcohol withdrawal symptoms in hospitalized patients","volume":"69","author":"Flygenring","year":"1984","journal-title":"Acta Psychiatr Scand"},{"key":"2022031410501332100_ref15","volume-title":"Goldfrank\u2019s Toxicologic Emergencies (Tenth ed)","author":"Gold","year":"2015"},{"key":"2022031410501332100_ref16","first-page":"51","article-title":"Slow-release carbamazepine for therapy of alcoholic predelirium: results of a double blind clinical trial using timonil 150 retard","volume":"5","author":"Gottesleben","year":"1994","journal-title":"Eur J Clin Res"},{"key":"2022031410501332100_ref17","first-page":"174","article-title":"A comparison of efficacy and safety of pregabalin and lorazepam in the treatment of mild to moderate alcohol withdrawal syndrome","volume":"115","author":"Gupta","year":"2014","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"2022031410501332100_ref18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40263-015-0240-4","article-title":"Anticonvulsants for the treatment of alcohol withdrawal syndrome and alcohol use disorders","volume":"29","author":"Hammond","year":"2015","journal-title":"CNS Drugs"},{"key":"2022031410501332100_ref19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/08039489409078138","article-title":"Delirium tremens and physical alcohol withdrawal: a double-blind comparison of phenobarbital and barbital treatment","volume":"48","author":"Hasselbalch","year":"1994","journal-title":"Nord J Psychiatry"},{"key":"2022031410501332100_ref20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0447.1979.tb04479.x","article-title":"Delirium tremens and related clinical states. Aetiology, pathophysiology and treatment","volume":"59","author":"Hemmingsen","year":"1979","journal-title":"Acta Psychiatr Scand"},{"key":"2022031410501332100_ref21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ajem.2009.10.010","article-title":"A prospective, randomized, trial of phenobarbital versus benzodiazepines for acute alcohol withdrawal","volume":"29","author":"Hendey","year":"2011","journal-title":"Am J Emerg Med"},{"key":"2022031410501332100_ref22","doi-asserted-by":"crossref","first-page":"E1522","DOI":"10.1503\/cmaj.191730","article-title":"Mortality among patients with frequent emergency department use for alcohol-related reasons in Ontario: a population-based cohort study","volume":"192","author":"Hulme","year":"2020","journal-title":"CMAJ"},{"key":"2022031410501332100_ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0924-977X(96)87301-9","article-title":"Double-blind comparative trial with carbamazepine vs diazepam treatment of alcohol withdrawal","volume":"6","author":"Kalyoncu","year":"1996","journal-title":"Eur Neuropsychopharmacol"},{"key":"2022031410501332100_ref24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1553-2712.2008.00187.x","article-title":"Predictors of mortality in patients with delirium tremens","volume":"15","author":"Khan","year":"2008","journal-title":"Acad Emerg Med"},{"key":"2022031410501332100_ref25","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/j.1530-0277.2007.00419.x","article-title":"Oxcarbazepine? Efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study","volume":"31","author":"Koethe","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"2022031410501332100_ref26","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1530-0277.2007.00344.x","article-title":"Antiglutamatergic strategies for ethanol detoxification: comparison with placebo and diazepam","volume":"31","author":"Krupitsky","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"key":"2022031410501332100_ref27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/00048678009159381","article-title":"Sodium valproate in the treatment of the alcohol withdrawal syndrome","volume":"14","author":"Lambie","year":"1980","journal-title":"Aust N Z J Psychiatry"},{"key":"2022031410501332100_ref28","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1300\/J069v21n02_05","article-title":"Divalproex sodium (Depakote) for alcohol withdrawal and relapse prevention","volume":"21","author":"Longo","year":"2002","journal-title":"J Addict Dis"},{"key":"2022031410501332100_ref29","doi-asserted-by":"crossref","first-page":"44","DOI":"10.5507\/bp.2013.089","article-title":"Alcohol withdrawal delirium\u2014diagnosis, course and treatment","volume":"159","author":"Mainerova","year":"2013","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"key":"2022031410501332100_ref30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1176\/ajp.146.5.617","article-title":"Double-blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal","volume":"146","author":"Malcolm","year":"1989","journal-title":"Am J Psychiatry"},{"key":"2022031410501332100_ref31","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.mcna.2010.08.010","article-title":"An approach to the patient with substance use and abuse","volume":"94","author":"Maldonado","year":"2010","journal-title":"Med Clin North Am"},{"key":"2022031410501332100_ref32","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ccc.2017.03.012","article-title":"Novel algorithms for the prophylaxis and management of alcohol withdrawal syndromes\u2013beyond benzodiazepines","volume":"33","author":"Maldonado","year":"2017","journal-title":"Crit Care Clin"},{"key":"2022031410501332100_ref33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1080\/10550490500419110","article-title":"A randomized, open-label, controlled trial of gabapentin and phenobarbital in the treatment of alcohol withdrawal","volume":"15","author":"Mariani","year":"2006","journal-title":"Am J Addict"},{"key":"2022031410501332100_ref34","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jnnp.2007.128322","article-title":"The alcohol withdrawal syndrome","volume":"79","author":"McKeon","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2022031410501332100_ref35","first-page":"CD005064","article-title":"Anticonvulsants for alcohol withdrawal","volume":"3","author":"Minozzi","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2022031410501332100_ref36","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40265-015-0358-1","article-title":"Identification and management of alcohol withdrawal syndrome","volume":"75","author":"Mirijello","year":"2015","journal-title":"Drugs"},{"key":"2022031410501332100_ref37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.rce.2014.11.013","article-title":"S\u00edndrome de abstinencia alcoh\u00f3lica en pacientes hospitalizados","volume":"215","author":"Monte-Secades","year":"2015","journal-title":"Rev Clinica Espanola"},{"key":"2022031410501332100_ref38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/alcalc\/agp087","article-title":"Analysis of the factors determining survival of alcoholic withdrawal syndrome patients in a general hospital","volume":"45","author":"Monte","year":"2010","journal-title":"Alcohol Alcohol"},{"key":"2022031410501332100_ref39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1530-0277.1983.tb05409.x","article-title":"Deficiencies of clinical trials of alcohol withdrawal","volume":"7","author":"Moskowitz","year":"1983","journal-title":"Alcohol Clin Exp Res"},{"key":"2022031410501332100_ref40","volume-title":"Alcohol Use Disorders: Diagnosis and Clinical Management of Alcohol-Related Physical Complications","author":"National Clinical Guideline Centre (NICE)","year":"2017"},{"key":"2022031410501332100_ref41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0278-5846(89)90004-3","article-title":"Double blind study on the efficacy and safety of tetrabamate and chlordiazepoxide in the treatment of the acute alcohol withdrawal syndrome","volume":"13","author":"Radouco-Thomas","year":"1989","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2022031410501332100_ref42","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0196-0644(94)70070-2","article-title":"The lack of efficacy of phenytoin in the prevention of recurrent alcohol-related seizures","volume":"23","author":"Rathlev","year":"1994","journal-title":"Ann Emerg Med"},{"key":"2022031410501332100_ref43","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/j.1530-0277.2001.tb02354.x","article-title":"Divalproex sodium in alcohol withdrawal: a randomized double-blind placebo-controlled clinical trial","volume":"25","author":"Reoux","year":"2001","journal-title":"Alcohol Clin Exp Res"},{"key":"2022031410501332100_ref44","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jemermed.2012.07.056","article-title":"Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study","volume":"44","author":"Rosenson","year":"2013","journal-title":"J Emerg Med"},{"key":"2022031410501332100_ref45","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1521-0391.1998.tb00336.x","article-title":"A pilot open randomized trial of valproate and phenobarbital in the treatment of acute alcohol withdrawal","volume":"7","author":"Rosenthal","year":"1998","journal-title":"Am J Addict"},{"key":"2022031410501332100_ref46","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0025-7125(05)70554-X","article-title":"Pharmacotherapies for alcohol abuse: withdrawal and treatment","volume":"81","author":"Saitz","year":"1997","journal-title":"Med Clin North Am"},{"key":"2022031410501332100_ref47","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/13556210500224015","article-title":"Oxcarbazepine versus carbamazepine in the treatment of alcohol withdrawal","volume":"10","author":"Schik","year":"2005","journal-title":"Addict Biol"},{"key":"2022031410501332100_ref48","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/1060028016629161","article-title":"A review of the treatment of severe alcohol withdrawal","volume":"50","author":"Schmidt","year":"2016","journal-title":"Ann Pharmacother"},{"key":"2022031410501332100_ref49","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1360-0443.1995.tb03551.x","article-title":"The histories of withdrawal convulsions and delirium tremens in 1648 alcohol dependent subjects","volume":"90","author":"Schuckit","year":"1995","journal-title":"Addiction"},{"key":"2022031410501332100_ref50","doi-asserted-by":"crossref","first-page":"107966","DOI":"10.1016\/j.neuropharm.2020.107966","article-title":"Mechanisms of action of currently used antiseizure drugs","volume":"168","author":"Sills","year":"2020","journal-title":"Neuropharmacology"},{"key":"2022031410501332100_ref51","first-page":"153","article-title":"Carbamazepine versus oxazepam in the treatment of alcohol withdrawal: a double-blind study","volume":"27","author":"Stuppaeck","year":"1992","journal-title":"Alcohol Alcohol"},{"key":"2022031410501332100_ref52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.eplepsyres.2006.09.008","article-title":"Pharmacology and mechanism of action of pregabalin: the calcium channel \u03b12-\u03b4 (alpha2-delta) subunit as a target for antiepileptic drug discovery","volume":"73","author":"Taylor","year":"2007","journal-title":"Epilepsy Res"},{"key":"2022031410501332100_ref53","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.brainres.2005.10.047","article-title":"Lorazepam and MK-801 effects on behavioral and electrographic indices of alcohol withdrawal sensitization","volume":"1065","author":"Veatch","year":"2005","journal-title":"Brain Res"},{"key":"2022031410501332100_ref54","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14423\/SMJ.0000000000000216","article-title":"Implementation of a CIWA-Ar alcohol withdrawal protocol in a veterans hospital","volume":"108","author":"Waye","year":"2015","journal-title":"South Med J"},{"key":"2022031410501332100_ref55","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jcrc.2014.10.008","article-title":"Multicenter evaluation of pharmacologic management and outcomes associated with severe resistant alcohol withdrawal","volume":"30","author":"Wong","year":"2015","journal-title":"J Crit Care"},{"key":"2022031410501332100_ref56","author":"World Health Organization","year":"2012"},{"key":"2022031410501332100_ref57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/10550490600625798","article-title":"Risk factors for delirium tremens: a retrospective chart review","volume":"15","author":"Wright","year":"2006","journal-title":"Am J Addict"},{"key":"2022031410501332100_ref58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jhg.2017.91","article-title":"The pharmacogenomics of valproic acid","volume":"62","author":"Zhu","year":"2017","journal-title":"J Hum Genet"}],"container-title":["Alcohol and Alcoholism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/alcalc\/article-pdf\/57\/2\/155\/42884760\/agab057.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/alcalc\/article-pdf\/57\/2\/155\/42884760\/agab057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T13:48:06Z","timestamp":1699278486000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/alcalc\/article\/57\/2\/155\/6350883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,13]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,8,13]]},"published-print":{"date-parts":[[2022,3,12]]}},"URL":"https:\/\/doi.org\/10.1093\/alcalc\/agab057","relation":{},"ISSN":["0735-0414","1464-3502"],"issn-type":[{"value":"0735-0414","type":"print"},{"value":"1464-3502","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2021,8,13]]}}}